The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Amlodipine Pinewood 5 mg Tablets

5 milligram(s) Tablet

Pinewood Laboratories Ltd,PA0281/165/001

Main Information

Trade NameAmlodipine Pinewood 5 mg Tablets
Active SubstancesAmlodipine besilate
Strength5 milligram(s)
Dosage FormTablet
Licence HolderPinewood Laboratories Ltd,
Licence NumberPA0281/165/001

Group Information

ATC CodeC08CA Dihydropyridine derivatives
C08CA01 amlodipine

Status

Authorised/WithdrawnAuthorised
Licence Issued22/02/2013
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back